ISSN 0859-547X
http://epid.moph.go.th/home_menu_20001.html
*
23 : 4&&
5 : 3 " 6378
Volume 35 : Number 9 :
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26
54 53 49 58 60 58 68 58 64
9 22 28 ก .. 2547
!"#$%&' #(ก#
9 # 64 "'#) 84.21
* .. 2547 #1
9ก:ก&!";&
9 22 - 28 ก .. 2547
(Outbreak Situation, 9 th Week February 22 28,
2004)
9 22 - 28 ก
.. 2547 "ก#$% &'#()'*ก+ก$,- (.&'
"+$ก/)0# "-12
1. Meningococcal meningitis 2 % +345'6% )*. 1 % (.%0 1 % 2
45'6%+7% 0% 10 8 0%5 65/1 5 2 /"#.ก0 0"+0) )*. +$
6% 16 ก
.. 2547 '%0ก&*' 9 0+)% ก#ก% +'0 +*'#กก9
,%#.) 18 ก
.. 2547 /0+*'#กก9,%#.1 19 ก
.. 2547 4.ก" CSF culture #+7:20 Neisseria meningitidis .กก90ก*;2+3ก/$
)"%ก.##' 27 ก
.. 2547 )กก0#,-# 45'6%+%0%572<;ก98 3 % 10 ก06% &&'+$&0: #'0%5ก. 45'4ก.'7$#' 6 % +:0#'-.ก-.
#'45'6% 5 % &')%% Rifampicin '# &&'" Throat swab ก0)%% "#+:0ก.'7$
,+%&'"ก+=>0%ก.'7$ *?2%&%45'6%+$*;2
ส า ร บั ญ
9ก:ก&!";& 9 22 - 28 ก .. 2547
ก&!"1ก#&';#&"#
ก&' @A(' "B
17 19 - 21 DE" .. 2547
9ก:!"
&""F 9 22 28 ก .. 2547
!"#$%&' ก&( 506 #H ก .. 2547
137
140
143
146
153
45'6%+7%0% 4 8 0%5 /"#.2"-0ก 0"+0+:0 )%0 +$6% 14
ก
.. 2547 '%0ก&*' D:20%'#0ก&*;2 7+%E);+*'#กก9,%#.
%0 (%
'%&##' +. 21.30 . &*' 0+)% 4:(// );"ก.#&ก9+3
45'6%
,%#.%0 (ก#0?5$ 39.6 0+D.+D% 17 ก
.. 2547 #/
(0':0 ,-$2
(:0* (.=6+'2 2 *' )(+.Eก F // " CSF culture # gram
Gve diplococci /)%:%ก$%/
ก(%
.กก90ก*;2+3ก/$ (%
)"%ก.#
#' 24 ก
.. 2547 )กก0#,-# #$ 07*%*0'/. (.
"45'6%&'%ก " Throat swab 45'4ก.'7$-0#- 3 - &'(ก #$ (. /)
ก$%/
ก(%
D;$/)*045'6%(.45'4 0%504.'0H$#/$ก
2. Pertussis 2 % 0"+0+:0 ).#
ก +3+Eก1$ 0% 4 8 0%5 5 14 /"#.,-ก/5 0"+0+:0 ).# +%0%5720#. 3
+$6% 20 ก
.. 2547 '%0ก-.'% &0 +)E#-0 +(.2"5ก +.:000ก/'+%:0#/*
)กกDก/$# +Eก&'#-D-#/+ก?I
45'4#'+3'0 1 - &'#-D-#/+ก?I
+7+%ก *?20กก/$
2 +3+Eก7%0% 12 8 0%5 5 1 /"#.,$J+ก'/' 0"+0+:0 ).# +%0%572
<;ก98 6 +$6% 10 ก
.. 2547 '%0ก&0/.0 &0ก+.ก.-: +.:000ก/'+%:0
#/* 0ก0+)%.ก&0 4.ก<%0ก #0กก/$ /$ก#-D)"&&'
+:0)ก/$ก&'#-D% 45'4#' 3 % 0% 1 G 3 8 D;&'#-D-#/+ก?I
*?2
0กก/$
45'6%2 2 % +*'#กก9+345'6%0ก,%#..# 24 ก
.. 2547
(%
" Nasopharyngeal swab /)ก$%/
ก(%
*?20%504.'0H$#/$ก
3. Food poisoning )กก/)0#*:0$
&%K L## 25 ก
..
2547 +Eกก+%*0 2 ,+%0"+0.ก )0% )" 96 - 2 -<# +$ก.#)ก
ก+*'-%.5ก+:0 0"+0/# )7.# ,%+$&+*'-%/2(/ 21 G 24 ก
.. 2547 ,%
24 ก
.. 2547 +$ก.#(#0ก. +.? 13.00 . '*%*'
(ก(;ก0<;/.0 )7.# .)ก2+.? 15.00 . +Eกก+%+$0ก'0
-.:&' 0+)% #-0ก<%+. &'(/MN2" )ก+.? 20.00 . 0)%
&'"+Eก
ก+%6% +*'#กก9,%#.#0$ 30 % +345'6%0ก 17 % 45'6% 13 % (.0ก
;+*'#กก9,%#.-0%% +345'6%0ก 20 % "#45'6%,%#.#0$
13 % (%
01/'ก.#&'ก% (.+$ก.#5$."+)0% +.? 12.00 . *0
25 ก
.. 2547
)กกก#"ก?*)-0%% ,%#.&&'" Rectal swab
(.&&'+กE#$/) +:0/)%:%'0H$#/$ก );&'ก#"ก?*)7.# '0#
,--%ก+%+*'ก"ก$)ก '0 ก"."+$ก*'05.+$+/$ "ก?*)
0% &''*'05.+$+/$+ก%ก#ก$)ก "70%5)7.# +:0()''"ก?*
)7.# -#-+=>:2 *?20%5"+$ก+7+%ก
138
Weekly Epidemiological Surveillance Report 2004 Vol. 35 No.9
ISSN 0859-547X . http://epid.moph.go.th/home_menu_20001.html
4. Severe diarrhoea 2 &'#% )ก 11 ) 74 % ก%/)#+7:20
Vibrio Cholerae
El Tor Inaba /2(//'8&'#%45'6%2$2 470 % +%7$/ 2 % ก)%
0%5 34 ) ,%45'6%'0%. 40 0%5+*/ก+- +:0ก
%45'6% 22 )
(176 %) +3)"ก 10 &'(ก ก+-(48 %) %0 (19 %)
-0%% (10 %) (7 %) # (6 %) )# (5 %) L+7$+ (4 %) / (3
%) .# (2 %) 7# (2 %) "(ก#4 #H
6 &'(ก ก (16 %)
*0(ก (11 %) $
(3 %) %, (1 %) ก.- (1 %)
+.% (1 %) "#H 4
&'(ก +7#5?
(22 %) ." (11 %) (1 %) +7% (1 %) ";( 2 &'(ก
ก# (1 %) *. (1 %)
8 .. 2547 #45'6%5ก8 .. 2546 7+.+%ก ,%#45'6%5/0+:0/2(/.%8 ..
2546 5
@IJ !" @
)"45'6%(%)
@ก #H ..2545 - 2547 #1
320
300
280
260
240
220
200
180
160
140
120
100
80
60
40
20
0
.-. .-. .-. ก.-. ก.%. .%. .-. .-. .-. ก.-. ก.%. .%. .-. .-. .-. ก.-. ก.%. .%.
2545
2546
2547
! ''( '
@&( D'ก
ก#$%&&' ก&' %+=>#$%)"
OPQR 8 SP L## T
ISSN 0859-547X . http://epid.moph.go.th/home_menu_20001.html
139
ก&!"1ก#&';#&"#
(Nipah/Hendra-like virus G Bangladesh Outbreak )
ก&"B@ก .. 2544
+:0 +9% <; W9- .. 2544 &'ก#*0,-&*'00ก+#5#'
Chandpur ) Meherpur $//ก*0+#-.+ (.0%5)ก7%(+0$+%
? 17 ก$,.+/ #45'6% 18 % +%7$/ 9 % 45'6%0ก&*'5 (.0ก## ,%
45'+%7$/ 7 %0%0%5#'.+%ก 0%,%+L.% 40 8 (0%/2(/ 32 - 60 8) +3+7% 6 % +
1$ 1 % %.)กก0#,-,%+)''?*+#-.+ ก#+)''0-
ก0%,.ก
(.4.ก$$)L%'0H$#/$ก,%$ ELISA5%
-#-(.>0ก,-K0+$ก(CDC)# 5$-'ก((0/$#0)/0+7:20&*'00ก+#
$
/Hendra like virus 45'6%
ก&"B
.. 2546
+:0 ก- .. 2546 &'ก#*0,-&*'00ก+#+L%#.5#' Chalksita (.
Biljoania ) Naogaon $//ก+L%+:0*0+#-.+ #45'6% 17 % 0%
4 <; 42 8 +%7$/ 8 % ,%45'6%0ก&*' 9 (.&5';ก/
กKกE&' ;ก&B 2 "B
+:0ก
.. 2546 &'ก0#,-,%+)''?*+#-.+ (.+)''
)ก5%
-#-(.>0ก,-K0+$ก (CDC) 5#' Chandpur ) Meherpur +:0;ก9
*0#+*/(.M))%+%ก#-2(ก (.ก0#,-5#' Chalksita (. Biljoania )
Naogaon +:0+/(.*0#+*/*0ก#-2 2 -?0#&'+กE#/0%+.:0)ก-5#'
Chanpur 119 % (.5#' Charksita (. Biljoania 89 % 0ก6%7,-# :0
+345'4ก#45'+%7$/ก#-2ก0 D;+3--0#-+%ก --'+-%5')ก :0+:0#'*0
45'6% /)'0H$#/$ก,%$ ELISA 4.ก$$)L%'0H$#/$ก# -5#' Chandpur 4
% (.-5#' Charksita (. Biljoania 4 % 5$-'ก ((0/$#0) /0+7:20&*'00ก+#$
/Hendra like virus 7%+.ก#2 2 -2&##-.ก?* (Health care
workers) (0ก6%(/0%
)กก;ก9ก#2 2 -2# 45'6%0ก&*' 9 (.&5';ก/ D;ก#)
Naogaon 45'6%/$ก4ก#=5ก45#'กก45'&745'6% ก#) Meherpur
45'6%/$ก4ก#,-/.0+. 2 ก06%กก45'&745'6% 0ก)ก2(.'%ก+กE#D)ก
/
.%7$ +7 ก -'- /
XM( ก$# (.* #$+?:2ก.'#'45'6% +:0$5)
5$-'ก
((0/$#0) /0+7:20&00ก+#$
/Hendra like virus 4.ก/)'0H$#/$ก# -'-(&ก
7$ Pteropus giganteus 5$-'ก/0+7:20&*'00ก+#$
/Hendra like virus 2 /)ก 44 /
(4.55%) (/&#5$-'ก/
7$0:
140
Weekly Epidemiological Surveillance Report 2004 Vol. 35 No.9
ISSN 0859-547X . http://epid.moph.go.th/home_menu_20001.html
ก&"B
.. 2547
4 ก- .. 2547 <; 8 ก
.. 2547 0-
ก0%,.ก&'#% 45'6% '%,-&*'00ก+# 42 % +%7$/ 14 % (.0%5ก0#,-0ก 45 % 4.ก/)
'0H$#/$ก# 45'6% 9 %5$-'ก ((0/$#0) /0+7:20&*'00ก+#$
/Hendra like virus ก
#*0,-+ก$*;2/0ก.*0+) Manikgani D;#45'6% 7 % +%7$/ 4 % (.)
Rajbari D;45'6% 35 % +%7$/ 10 %
@ก&!"1ก#&';#&"# "B
1 3
&
ก#*0,-&*'00ก+#+*/-//ก -//ก+L%+:0 (.-ก.*0+#-.
+ 3 -2 8 .. 2544, 2546 (. 2547 /."# 45'6%0ก&*' 9 (.&5';ก/ 45'6%
5$-'ก/0+7:20&*'00ก+#$
/Hendra like virus )กก;ก9#$%# ก4ก#/
+3
.กK# ,-2+3,-/$/0)ก/
5- (.#-'-0)+3(.,-7/$
&':
)กก#*0,-&*'00ก+#+#-.+ <;(')#45'6%5$-'ก ((0/$#0) /0+7:20
&*'00ก+#$
/Hendra like virus (/ก/)5$-'ก0)+ก$)ก+7:20&0: (0/$+)*'กก#
&
&*'00ก+#$
&' 2M))%+%*0ก6%ก.45'4$-.*045'6% (.ก/$/0
-%&&'ก$5)
&##-.ก?* (Health care workers) 0ก6%)กก#-2
2 (.2M))%+%*0ก+ก$,- )กก4ก#ก(.,-%&&'#ก%:% (/0%&กE/;ก#
0)+ก$)ก+7:20&&*'00ก+#$
&'
%+=>#$%)"
OPQR 8 SP L## T
ISSN 0859-547X . http://epid.moph.go.th/home_menu_20001.html
141
,-&*'00ก+#$
+ก$)ก+7:20&&*'00ก+#$
+3 RNA & /ก5.
Paramyxoviridae /
,-"-1 -:0 -'- D;<(+7:20&5/
7$0: +7 ก&' ก/$/0
ก'%ก (.กก#- +ก$)กก4,%/ก#+.:0 M :00))*0/
6% (.ก4ก#
.00+ก$)กก&0 (Coughing droplet) 0ก)ก2(.'%#+7:20&<5ก*#00กก#2"+7:20*00
ก
/
7$0: F +7 * ( ' (.( </$+7:20)กก4ก#ก6% กก$Dก*0/
6%/% ก
ก$2":000:ก+YZ0&ก#$-.*0/
6% 0%&กE/%&#.กK ก/$/0)ก/
+.2&5- (.&#.กKก/$/0-
ก#5$-+0+7%#ก#-2(ก++.+D%+:0ก%% .. 2541 <;+:0
W9- .. 2542 K+ก K+ก$+D#$. (.K.0 #45'6%2 265 % +%7$/ 105 % (.
ก#+$-,
+:0- .. 2542 #45'6% 11 % +%7$/ 1 % 45'6%1/$
4ก#ก6%
+ก57&'ก+กE#/0%D*0-'-(&ก-ก. (Pteropus lylei) //-(;
+:0+1 -'-+.2<5ก)#)ก)ก") 4.ก/))ก'0H$#/$ก#5$-'ก ((0/$#0)
/0+7:20&*'00ก+#$
/Hendra like virus )" 11 /0% )ก 96 /0%
)กก#*0,-&*'00ก+#0)+ก$)ก+7:20&&*'00ก+#$
(.ก/)#5$-'ก/0+7:20
&*'00ก+#$
/Hendra like virus -'-(&ก +#-.+D;0?+*//$/0ก#
+%
/.0)ก/)#5$-'ก/0+7:20&*'00ก+#$
/Hendra like virus-'-(&ก+
ก57 (.ก#*0,-&*'00ก+#++.+D%(.$-,
)+E&' +ก.0?+*/
/$/0ก#+&% :00?+*//$/0ก#++:0#'*0+&% -'-D;+3/
,-<#$
ก$&'&ก. 0)"+7:20
&/$/05=5-'-0: (.'/$/0&%/
D;</$/0&5-&'
ก2 ก?*&'ก#ก/
+:0+=>(.0# /-5:0ก"+$+=>
0#(.-#-ก.0ก&*'00ก+# +&% /2(/8 .. 2542 (.' (.&'()'+/:0ก#*0,&*'00ก+#$
&%"ก?*) (."ก>0ก-#-,-ก( +:0+/%-'0ก
+=>(.0#/(+-%'&' "#-5'(.(ก+.%(.& "ก#$%)"()'
Website URL: http:// epid.moph.go.th (.%+=>#$%)"
/0&
#ก'
1. ก0#$% ก?*. -5:0ก"+$+=> 0# (.-#-ก.0ก&*'00ก+#
+&%. #: ก0#$% ก?*; 2542.
2. Olson JG, Rupprecht C, Rollin PE, An US, Niezgoda M, Clemins T, et al.
Antibodies to Nipah-like virus in bats (Pteropus lylei), Cambodia. Emerg Infect Dis.
2002 Sep; 8(9): 987-8.
3. ProMED-mail. Nipah/Hendra-like virus - Bangladesh (2001/2003). ProMED-mail
[serial online] 2004; 2 Feb: 20040202.0398. [cited 2004 Feb 2]. Available from:
URL: http://www.promedmail.org.
4. ProMED-mail. Nipah/Hendra-like virus - Bangladesh (2001). ProMED-mail
[serial online] 2002; 30 Aug: 20020830.5187. [cited 2004 Feb 2]. Available from:
URL: http://www.promedmail.org.
# &# ! (@ ก'L Aก @ (@ ' A#กE 142
Weekly Epidemiological Surveillance Report 2004 Vol. 35 No.9
ISSN 0859-547X . http://epid.moph.go.th/home_menu_20001.html
+
#,ก&' #A'F ก&' ก'Aกก @I; I'Aก#H
#;
ก&' @A(' "B
17 19 21 DE" .. 2547
: !@'#"'@ก ก#"
กM&&@(N&' ก&' "@;ก@&" ก
17 19 - 21 #$%&
#.(. 2547
ก&" 1. (##X0
*0#-%0)ก0#'% #-%0 (./#-%0 )+3*07:0+:0
-?45'$)%(.<" "#/#-%0)ก0#'% 4 "-1 -:0 .กก(.+/4.
/<-
$ก;ก9 4.ก;ก9 (.5
2. ก$
#-%0 '$
/(##X0
ก" -:0 %ก0#* ก' 11.5 +D/$+/ 5 17
+D/$+/ 7'/0ก9(## (font) EucrosiaUPC * (size) 14 (.)$
&+ก$ 2 '
<'#+3)"-" 9&%&+ก$ 500 -" 90กW9&+ก$ 300 -" 22&#
#-%0 (5-"0$#%(##X0
/0%ก0#) $ก#-"7',(ก MS word
3. )"#-%0+39&% :0+390กW9กE&' (//'07:0+:02 2 9
4. 7:0+:0 $
'%.ก9?0ก97$/ (Bold) 29&%(.0กW9
5. #-%0 "##-%0+390กW9 '$
'%0ก9/$
12
6. $
7:0-?45'$)%(.<"#/0 ,%'7:045'"+04.$)%+37:0(ก '02*+'
/'7:045'"+04.$)% ()"-?45'$)%$
'&+ก$ 6 - <'กก2'7'/'%-" (.
-?) .)ก$
7:0-?45'$)%-#ก-(.' '$
<"*045'$)%(/.-+%/."# ,%
7'1.ก9?
(/+.*) +7:0,%7:045'$)%(.<" '7'1.ก9?
/."#ก0.
7. ก7'/%0(.1.ก9?
'+3&/ก"/K (.7'+)"+3 %ก+'+:0ก.<;-2(ก'7'
/+/E '7'/%0 "##-" 0ก9/%0)+35')กก(.' );&)"+3/'07'/+/E +7 AIDS,
HIV +3/'
8. #-%0")&2 )/'00%55(##/-?กก)ก[ก"กก +:0'0
))"5+.*0:0#-%0&' -?กก)$)?-?*04.$)% +:0"+0
+2 )&$)?(ก'&**'0- ":05(##ก"+0*0#-%0
%+=>#$%)"
OPQR 8 SP L## T
ISSN 0859-547X . http://epid.moph.go.th/home_menu_20001.html
143
"@
"&
1. ก#-%0 '%ก"+. -:0 % 15 - .. 2547 ก7'กก" )
&#ก$)? ,%'&-?กก$7กก#$%(7/$ "ก#$% ก
-#-,- ก ?* </$
0"+0+:0 )# 11000
2. ก)#-%0&+:0$)? *0',%$ก/ F 2
2.1
E-mail
&
[email protected]
: 0
[email protected] (.)+0ก/&%.
2.2
(4(+.Eก (diskette) '0+0กL##+3/)$
2.3
&##-%0,
3. ก$)?-+.:0ก#-%0 )ก",%-?กก45'- ?\$ )กก?*(.
$%.% -+7%71(/.*$72 F
4. ก"+04.$)%)(#00ก+3 2 + -:0 Oral Presentation (. Poster
Presentation #-%04ก$)?)ก-?กก(.' )<5กก"+*0ก"+0 D;
ก$)?ก"+*0ก"+0'ก##-%0+:02 *;2ก#-?-+:20(.-+
*0#-%0+*' D;0)&/ก#--
*045'#-%0&
5. #-%0&'#-+.:0ก'"+0'%$ Oral Presentation )'+.ก"+0 10 Dก<(.'*'0+0( 5 #-%0&'#+.:0ก'"+0'%$ Poster Presentation
45'$)%)/'00%5#$+?/$ Poster 7+.ก"' +:0)&'#%%ก0#ก# Poster "+0
6. #-%0&'#-+.:0ก'"+0 (.&'ก"+0 )&'#ก%#/#0ก"+0'
7. #-%0&'#-+.:0ก'"+04. )"&)$
.:0#-%0ก+:0
8. ก'-)/0ก)"#-%0(.-"("-# )+3ก7%+$-?*0#-%0(.
+$,0ก*0ก&'#$)?-+.:0ก0ก'%
/$/0*0*'05.+$+/$+ก%ก#ก4.$7ก &'
ก.+$#$7ก "ก#$% ก-#-,- ก?* 11000
,.0-2590-1734-5 , 0-2590-1784
E-mail
144
[email protected] H
[email protected]
Weekly Epidemiological Surveillance Report 2004 Vol. 35 No.9
ISSN 0859-547X . http://epid.moph.go.th/home_menu_20001.html
( @&&O"'& &'&" ก&' @A(' "B
17
19 - 21 DE" .. 2547
AH
#H
(E1 ) ]]]]]]]]]]]]]]]]]]]]]]]]].................
(EกDE) ]]]]]]]]]]]]]]]]]]]]]]]....................
-?45')$ % ]]]]]]]]]]]]]]]]]]]]]]]]]]]]..................
<" ]]]]]]]]]]]]]]]]]]]]]]....................................
กก@#(I: ก.<;-+3:0-"-1*0M1ก$)%0%2ก
(.&')-
(9": ก.<;/$K (.+>%*0ก;ก9$)% 0%2 ก (.
(.&')-
'กKกE: 0$#%<;0-
ก0#"-1*0ก00ก(##ก;ก9 2
1. 7$*0ก;ก9#$% (Study Design)
2. กก"*/0%(.$ก +.:0ก/0%
3. /(7'4.ก;ก9
4. <$/$7'ก$+-
IกKกE: 0$#%<;4.ก;ก9"-1 0-.'0ก#$ก;ก9
: 4.ก;ก90%2 ก(.7+) ,%+'<;-"-1(.
4.ก#*0ก;ก9 2*'0+0(+:0ก\:0(ก'M1
Key word:
*'+)'*0#-%0 +:0"+0ก#$%(7/$ -2 17 .ก9?
Oral presentation
Poster presentation
• @&&กE
;A;ก' ;;A EucrosiaUPC 14
• ' ;ก& 11.5 X 17 #P('#( (( ( 1#ก' 2 (ก&) .
&#)" E1 1#ก' 500 " EกDE1#ก' 300 " (1AH
#H
":I' @
9
)
7:045' ]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]] (*0'$
7:0Gก. 29&%(.0กW9)
</$/0]]]]]]]]]]]]]]]]]]]]]]]]]]]]]
,
]]]]]]]..,]]]]]]]]. (. E-mail address (<') ]]]]]]]]]]]]]]]]]]]]
%+=>#$%)"
OPQR 8 SP L## T
ISSN 0859-547X . http://epid.moph.go.th/home_menu_20001.html
145
9ก:!"
&""F 9
22 28 ก .. 2547
Summarize of the Priority Diseases Occurrence,
9 th Week February 22 28, 2004
"ก#$%&')(#ก%,-."#-"-15+3 2 ก. &'(ก ก.,-/'0%<;"ก
#$%% 24 7,#)ก#ก9 13 ,- (.ก.,-/'0%% 1 #)ก#ก9 9
,- /&'ก+4%(%+=>#$%)"
8 35 L## 1 &(.' )ก%45'6%,."#-"-15&'#%
9 (/ 1) # ,-)"45'6%กก
+%ก*08
.. 2546 (.กก%K 5 8%'0.)" 5 ,- &'(ก &*'ก^.(0, ก.0กก.'+:200/00
ก+8%ก(##+L%#., 0))0%(, :0 +' ก (.0#/'0+*'#กก9,%#.
&*'ก^.(0&'#%45'6% 1 %)ก)- 0))0%(&'#%45'6% 37 %
)ก 9 ) &'(ก )ก.- 19 % %0 7 % *0(ก 5 % (.0ก 6 )F . 1 % (/ 2)
,-:0 +' ก&'#%45'6% 18 %)ก 6 ) &'(ก )+%(.*0(ก). 6 % ."(.
0#."5 ). 2 % 7%(.(ก'). 1 % )"45'6%&'#%,-0))0%((.
:0 +' ก /2(//'8<; 491 (. 299 % /."# +$*;2กก7+.+%ก*084 (.%Kก
)-+"+$/ก>0ก-#-
0#/'0+*'#กก9,%#. &'#%45'6% 513 %)ก 38 ) &%45'+%7$/
22+34.:#+:0)กก#*0,-&*'ก "'/'0+$-+*'ก5(.ก9(.ก+=>ก*;2 D;
#&' #-:0 )กก )+30% )%45'6%ก 5 0 #(ก
2 &'( ก
+7%% 97 % 0/$/<
40 % ก# 37 % -7 30 % (.)#-*
29 %
! ( I(''
กM&&@(N&' ก&' 146
Weekly Epidemiological Surveillance Report 2004 Vol. 35 No.9
ISSN 0859-547X . http://epid.moph.go.th/home_menu_20001.html